- Gasbarrini A, Franceschi F, Tartaglione R, et al. Regression of autoimmune thrombocytopenia after eradication of Helicobacter pylori. Lancet. 1998;352(9131):878. doi:https://doi.org/10.1016/S0140-6736(05)60004-9.
- Vanegas YAM, Vishnu P. Management of Helicobacter pylori in patients with immune thrombocytopenia. Hamostaseologie. 2019;39(3):279–283. doi:https://doi.org/10.1055/s-0039-1683974.
- Zain MA, Zafar F, Ashfaq A, et al. Helicobacter pylori: an underrated cause of immune thrombocytopenic purpura. A comprehensive review. Cureus. 2019;11(9):e5551. doi:https://doi.org/10.7759/cureus.5551.
- Payandeh M, Raeisi D, Sohrabi N, et al. Poor platelet count response to Helicobacter pylori eradication in patients with severe idiopathic thrombocytopenic purpura. Int J Hematol Oncol Stem Cell Res. 2013;7(3):9–14.
- Jiménez-Soto LF, Haas R. The CagA toxin of Helicobacter pylori: abundant production but relatively low amount translocated. Sci Rep. 2016;6:23227. doi:https://doi.org/10.1038/srep23227.
- Kodama M, Kitadai Y, Ito M, et al. Immune response to CagA protein is associated with improved platelet count after Helicobacter pylori eradication in patients with idiopathic thrombocytopenic purpura. Helicobacter. 2007;12(1):36–42. doi:https://doi.org/10.1111/j.1523-5378.2007.00477.x.
- Rinaldi M, Perricone C, Ortega-Hernandez OD, et al. Immune thrombocytopaenic purpura: an autoimmune cross-link between infections and vaccines. Lupus. 2014;23(6):554–567. doi:https://doi.org/10.1177/0961203313499959.
- Cheng YS, Kuang LP, Zhuang CL, et al. Effects of cytotoxin-associated gene A (CagA) positive Helicobacter pylori infection on anti-platelet glycoprotein antibody producing B cells in patients with primary idiopathic thrombocytopenic purpura (ITP). Pak J Med Sci. 2015;31(1):121–126. doi:https://doi.org/10.12669/pjms.311.6409.
- Takahashi T, Yujiri T, Shinohara K, et al. Molecular mimicry by Helicobacter pylori CagA protein may be involved in the pathogenesis of H. pylori-associated chronic idiopathic thrombocytopenic purpura. Br J Haematol. 2004;124(1):91–96. doi:https://doi.org/10.1046/j.1365-2141.2003.04735.x.
- Frydman GH, Davis N, Beck PL, et al. Helicobacter pylori eradication in patients with immune thrombocytopenic purpura: a review and the role of biogeography. Helicobacter. 2015;20(4):239–251. doi:https://doi.org/10.1111/hel.12200.
- Kuwana M. Helicobacter pylori-associated immune thrombocytopenia: clinical features and pathogenic mechanisms. World J Gastroenterol. 2014;20(3):714–723. doi:https://doi.org/10.3748/wjg.v20.i3.714.
- Dotan E, Katz R, Bratcher J, et al. The prevalence of pantoprazole associated thrombocytopenia in a community hospital. Expert Opin Pharmacother. 2007;8(13):2025–2028. doi:https://doi.org/10.1517/14656566.8.13.2025.
- Laine L, Barkun AN, Saltzman JR, et al. ACG clinical guideline: upper gastrointestinal and ulcer bleeding. Am J Gastroenterol. 2021;116(5):899–917. doi:https://doi.org/10.14309/ajg.0000000000001245.
Immune thrombocytopenic purpura secondary to Helicobacter pylori
Reprints and Corporate Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
To request a reprint or corporate permissions for this article, please click on the relevant link below:
Academic Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
Obtain permissions instantly via Rightslink by clicking on the button below:
If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.